APA (7th ed.) Citation

Kumar, P., Singh, K., Ray, A., Kumari, A., Chatterjee, S., Hernandez, H., & Roy, A. D. (2026, December). Economic implications of switching to the hexavalent infant vaccine in an immunization program in India. Human Vaccines & Immunotherapeutics.

Chicago Style (17th ed.) Citation

Kumar, Pawan, Kapil Singh, Arindam Ray, Amrita Kumari, Susmita Chatterjee, Homero Hernandez, and Arup Deb Roy. "Economic Implications of Switching to the Hexavalent Infant Vaccine in an Immunization Program in India." Human Vaccines & Immunotherapeutics Dec. 2026.

MLA (9th ed.) Citation

Kumar, Pawan, et al. "Economic Implications of Switching to the Hexavalent Infant Vaccine in an Immunization Program in India." Human Vaccines & Immunotherapeutics, Dec. 2026.